Amylyx acquires avexitide GLP-1ra post-bariatric hypoglycaemia from Eiger BioPharmaceuticalsAmylyx Pharmaceuticals has acquired avexitide from Eiger BioPharmaceuticals, an investigational, first-in-class glucagon-like peptide-1...
Eiger BioPharmaceuticals to focus Avexitide for hyperinsulinemic hypoglycaemia indicationsEiger BioPharmaceuticals has revealed it will focus its development efforts on advancing avexitide in hyperinsulinemic hypoglycaemia...
Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemiaPhase 2b results of avexitide (Eiger BioPharmaceuticals) in patients with post-bariatric hypoglycemia (PBH) and hyperinsulinemic...
IFSO Bariatric Endoscopy Committee endorses endoscopic sleeve gastroplasty as an effective and valuable treatment for obesity2 days ago
BMS reduces obesity-related pregnancy complications but introduces potential risks that may result in adverse outcomes2 days ago